| Title | Author(s) | Year | View Count |  | High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B | Pan, CQ; Tong, M; Kowdley, KV; Hu, K; Chang, T; Lai, C; Yoon, SK; Lee, SS; Cohen, D; Tang, H; Tsai, N | 2012 | 88 |
| A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B | Lai, CL; Ahn, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NW; Kwon, YO; Sohn, JH; Lee, JY; Park, HE; Kim, JA; Han, KH; Yuen, MF | 2011 | 211 |
| Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B | Lai, CL; Ahh, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NH; Kweon, YO; Sohn, JH; Lee, J; Kim, JA; Han, KH; Yuen, MF | 2011 | 61 |
 | Long-term entecavir treatment for up to 5 years in Asians with HBEAG-positive nucleos(T)ide naïve chronic hepatitis B: results from ETV-022 and -901 | Pan, C; Tong, MJ; Kowdley, KV; Hu, KQ; Chang, TT; Lai, CL; Yoon, SK; Lee, SS; Cohen, DS; Tang, H; Tsai, N | 2010 | 126 |
| Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B | Chang, TT; Lai, CL; Yoon, SK; Lee, SS; Coelho, HSM; Carrilho, FJ; Poordad, F; Halota, W; Horsmans, Y; Tsai, N; Zhang, H; Tenney, DJ; Tamez, R; Iloeje, U | 2010 | 116 |
| Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease | Yuen, MF; Han, KH; Um, SH; Yoon, SK; Kim, HR; Kim, J; Kim, CR; Lai, CL | 2010 | 73 |
| Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV | Lai, CL; Han, KH; Yoon, SK; Um, SH; Yuen, MF; Kim, HS; Kim, HR; Chung, HC; Kim, CR; Hsyu, P; Averett, D; Worland, S; Kim, J | 2006 | 213 |
|
